Glenn Washer

Glenn Washer, holds dual roles at Frontage. As the President of Frontage Laboratories, North America he is responsible for operational and financial performance of the North American businesses. As the Executive Vice President for Global Safety and Toxicology, Glenn is responsible for the overall leadership and the strategic global growth of the Safety/Toxicology business at Frontage Laboratories.

Glenn has over 35 years experience in the drug development industry.  Prior to joining Frontage, he served as President of Charles River’s Canadian preclinical businesses, and as Senior Vice President responsible for Charles River’s North America Safety Assessment business unit.  Previously he served as VP Toxicology at ITR Laboratories and at LAB Research Inc.

Glenn graduated from McGill University in 1989 and was Certified as a Diplomat of the American Board of Toxicology in 1999.  He has served as a Faculty Member with the Washington-DC-based Pharmaceutical Education & Research Institute, served on the Editorial Board for the International Journal of Toxicology, and has lectured on toxicology for the Society of Toxicology, the Drug Information Association, the Society of Quality Assurance, McGill University and Universite de Montreal.  In addition, he has served as a board member for multiple life-sciences industry organizations, and is certified as a corporate director by the Institute of Corporate Directors.